Impact of direct-to-consumer genomic testing at long term follow-up
The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
Background: There are few empirical data to inform the debate surrounding the use and regulation of direct-to-consumer (DTC) genome-wide disease risk tests. This study aimed to determine the long term psychological, behavioural, and clinical impacts of genomic risk testing for common disease. Methods: The Scripps Genomic Health Initiative is a prospective longitudinal cohort study of adults who purchased the Navigenics Health Compass, a commercially available genomic test. Web based assessments were administered at baseline, short (3 months), and long term (1 year) follow-up. Results: 2240 participants completed either or both follow-ups and a subset of 1325 completed long term follow-up. There were no significant differences from baseline in anxiety (p=0.50), fat intake (p=0.34), or exercise (p=0.39) at long term follow-up, and 96.8% of the sample had no test related distress. Longitudinal linear mixed model analyses were consistent with results of cross-sectional analyses. Screening test completion was associated with sharing genomic test results with a physician (36.0% shared; p<0.001) and perceived utility of the test (61.5% high perceived utility; p=0.002), but was not associated with the genomic risk estimate values themselves. Conclusions: Over a third of DTC genomic test recipients shared their results with their own physician during an approximate 1 year follow-up period, and this sharing was associated with higher screening test completion. Genomic testing was not associated with long term psychological risks, and most participants reportedly perceived the test to be of high personal utility.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A rapid food screener to assess fat and fruit and vegetable intake
Block, G., Gillespie, C., Rosenbaum, E. H., & Jenson, C. (2000) · American Journal of Preventive Medicine · doi:10.1016/s0749-3797(00)00119-7 · Cited by 565
An agenda for personalized medicine
Ng, P. C., Murray, S. S., Levy, S., & Venter, J. C. (2009) · Nature · doi:10.1038/461724a · Cited by 330
Cited by
Botkin, J. R., Belmont, J. W., Berg, J. S., Berkman, B. E., Bombard, Y., Holm, I. A., Levy, H. P., Ormond, K. E., Saal, H. M., Spinner, N. B., et al. (2015) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2015.05.022 · Cited by 898
Celis-Morales, C., Livingstone, K. M., Marsaux, C. F. M., Macready, A. L., Fallaize, R., O’Donovan, C. B., Woolhead, C., Forster, H., Walsh, M. C., Navas-Carretero, S., et al. (2016) · International Journal of Epidemiology · doi:10.1093/ije/dyw186 · Cited by 399
“Disclosing the outcomes of genomic testing in 2240 participants was not associated with changes in behavioural outcomes (fat intake or exercise) after 3 or 12 months.(22) In contrast, a recent Canadian RCT in young adults, comparing the effectiveness of four pieces of personalized genotype-based dietary advice with co…”
Direct-to-consumer genomics on the scales of autonomy
Vayena, E. (2015) · Journal of Medical Ethics · doi:10.1136/medethics-2014-102026 · Cited by 62
Puryear, L., Downs, N., Nevedal, A., Lewis, E. T., Ormond, K. E., Bregendahl, M., Suarez, C. J., David, S. P., Charlap, S., Chu, I., et al. (2018) · Journal of Community Genetics · doi:10.1007/s12687-017-0349-x · Cited by 31
Metadata
- Authors
- Bloss, C. S., Wineinger, N. E., Darst, B. F., Schork, N. J., & Topol, E. J.
- Venue
- Journal of Medical Genetics
- Publisher
- BMJ
- Published
- 2013-04-04
- Volume
- 50
- Issue
- 6
- Pages
- 393-400
- ISSN
- 0022-2593 (ISSN-L)
- 1468-6244
- OpenAlex
- W2120118206
- Cited by
- 137
- References
- 2
- FWCI
- 13.47
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Impact of direct-to-consumer genomic testing at long term follow-up. https://app.cochat.ai/papers/10.1136/jmedgenet-2012-101207
- The paper
- Bloss, C. S., Wineinger, N. E., Darst, B. F., Schork, N. J., & Topol, E. J. (2013). Impact of direct-to-consumer genomic testing at long term follow-up. Journal of Medical Genetics. https://doi.org/10.1136/jmedgenet-2012-101207
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.